| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 211.828 | 239.076 | 211.763 | 185.639 | 398.950 | 703.496 | 784.677 | 846.882 | 908.253 | 296.978 |
| Total Income - EUR | 213.567 | 240.229 | 216.239 | 188.757 | 403.578 | 706.330 | 786.515 | 850.577 | 911.741 | 345.146 |
| Total Expenses - EUR | 190.050 | 217.180 | 190.404 | 183.810 | 370.401 | 691.130 | 771.842 | 836.096 | 620.869 | 327.179 |
| Gross Profit/Loss - EUR | 23.517 | 23.048 | 25.835 | 4.947 | 33.177 | 15.200 | 14.673 | 14.481 | 290.871 | 17.967 |
| Net Profit/Loss - EUR | 19.754 | 19.325 | 22.669 | 3.080 | 29.187 | 8.165 | 6.807 | 6.083 | 245.263 | 15.092 |
| Employees | 4 | 5 | 5 | 4 | 7 | 8 | 9 | 10 | 9 | 6 |
Check the financial reports for the company - Mavirofarm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 12.217 | 10.658 | 8.541 | 6.078 | 4.263 | 26.909 | 31.666 | 22.589 | 15.765 | 10.998 |
| Current Assets | 129.155 | 160.444 | 166.752 | 240.531 | 401.092 | 386.928 | 668.793 | 414.279 | 390.606 | 320.703 |
| Inventories | 94.004 | 118.592 | 139.232 | 165.717 | 315.967 | 253.018 | 181.628 | 210.712 | 205.224 | 180.663 |
| Receivables | 25.220 | 5.561 | 26.221 | 71.415 | 77.426 | 109.337 | 283.683 | 98.108 | 123.449 | 113.711 |
| Cash | 9.931 | 36.291 | 1.299 | 3.400 | 7.699 | 24.573 | 203.482 | 105.459 | 61.933 | 26.329 |
| Shareholders Funds | 45.029 | 63.904 | 85.500 | 87.019 | 114.521 | 91.889 | 94.871 | 9.553 | 184.748 | 76.471 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 96.343 | 107.198 | 89.793 | 159.589 | 290.834 | 321.947 | 605.588 | 427.315 | 221.624 | 255.230 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Mavirofarm Srl